{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-082433","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2026-07-10T12:06:31+00:00","discovered_at":"2026-07-10T12:10:00.273625+00:00","generated_at":"2026-07-10T12:10:10.527440+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"VYNE declares special cash dividend of $0.38/share in connection with Yarrow merger","bullets":["Estimated aggregate $16.5M special cash dividend ($0.38/share) declared; record date July 22, 2026.","Dividend conditioned on closing of merger with Yarrow Bioscience; expected close on/about July 24, 2026.","Stockholder vote on merger scheduled for July 16, 2026; dividend payable after close.","Per-share amount based on 42,989,506 shares and equivalents outstanding as of July 9, 2026.","Actual distribution may be higher or lower than estimate; payment to transfer agent on July 23, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-082433","json":"https://secwatch.observer/filing/0001104659-26-082433.json","markdown":"https://secwatch.observer/filing/0001104659-26-082433.md","text":"https://secwatch.observer/filing/0001104659-26-082433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/0001104659-26-082433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/tm2620182d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T12:10:10.527440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}